TREATMENT OF ESSENTIAL HYPERTENSION WITH TRIMAZOSIN, A NEW VASODILATOR AGENTVLACHAKIS ND; MENDLOWITZ M; DE GUIA DE GUZMAN D et al.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 17; NO 6; PP. 564-569; BIBL. 16 REF.Article

Proceedings of the symposium on antihypertensive agents and coronary heart disease risk factors: focus on trimazosin, May 25-26, 1982, Proticcio, CorsicaLEREN, P; REID, J; BIRKENHÄGER, W et al.The American heart journal. 1983, Vol 106, Num 5, pp 1189-1284, issn 0002-8703Conference Proceedings

The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha₁-adrenoceptor responsiveness of trimazosin in manVINCENT, J; ELLIOTT, H. L; MEREDITH, P. A et al.European journal of clinical pharmacology. 1985, Vol 29, Num 3, pp 301-306, issn 0031-6970Article

LONG-TERM VASODILATOR THERAPY WITH TRIMAZOSIN IN CHRONIC CARDIAC FAILUREWEBER KT; KINASEWITZ GT; WEST JS et al.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 303; NO 5; PP. 242-250; BIBL. 33 REF.Article

Chronic alpha-adrenoceptor blockade with trimazosin in congestive heart failureKIRLIN, P. C; SUNIL DAS; PITT, B et al.International journal of cardiology. 1985, Vol 8, Num 1, pp 89-92, issn 0167-5273Article

THE CARDIOVASCULAR EFFECTS OF TRIMAZOSINCONSTANTINE JW; HESS HJ.1981; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1981; VOL. 74; NO 2-3; PP. 227-238; BIBL. 1 P.Article

CARDIAC MUSCLE MASS DURING VASODILATATION THERAPY OF HYPERTENSIONDRAYER JIM; GARDIN JM; WEBER MA et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 19; NO 6; PP. 727-732; BIBL. 19 REF.Article

HEMODYNAMIC EFFECTS OF TRIMAZOSIN IN PATIENTS WITH LEFT VENTRICULAR FAILURE.FRANCIOSA JA; COHN JN.1978; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1978; VOL. 23; NO 1; PP. 11-18; BIBL. 19 REF.Article

CARDIOCIRCULATORY ACTIONS OF TRIMAZOSIN AND SODIUM NITROPRUSSIDE IN ISCHEMIC HEART DISEASEAWAN NA; HERMANOVICH J; VERA Z et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 3; PP. 290-296; BIBL. 23 REF.Article

Racial differences in drug responses ― a comparative study of trimazosin and α₁-adrenoceptor responses in normotensive Caucasians and West AfricansVINCENT, J; ELLIOTT, H. L; MEREDITH, P. A et al.British journal of clinical pharmacology. 1986, Vol 21, Num 4, pp 401-408, issn 0306-5251Article

EFFECTS OF TIODAZOSIN, PRAZOSIN, TRIMAZOSIN AND PHENTOLAMINE ON BLOOD PRESSURE, HEART RATE AND ON-PRE- AND POSTSYNAPTIC ALPHA -ADRENERGIC RECEPTORS IN THE RATBUYNISKI JP; PIRCIO AW; SCHURIG JE et al.1980; CLIN. EXP. HYPERTENS.; ISSN 0148-3927; USA; DA. 1980; VOL. 2; NO 6; PP. 1039-1066; BIBL. 3 P.Article

EFFECT OF TRIMAZOSIN, METHYLDOPA, AND PLACEBO ON HYPERTENSION.ARONOW WS; OBERMAN A; POOL PE et al.1978; CURR. THERAPEUT. RES.; U.S.A.; DA. 1978; VOL. 23; NO 4 PART. 1; PP. 448-454; BIBL. 9 REF.Article

The effects of trimazosin and pindolol on serum lipids, blood glucose and serum insulin levelsLEHTONEN, A.Acta medica Scandinavica. 1985, Vol 218, Num 2, pp 213-216, issn 0001-6101Article

EFFECT OF THE VASODILATOR TRIMAZOSIN VERSUS PLACEBO ON EXERCISE PERFORMANCE IN CHRONIC LEFT VENTRICULAR FAILURE.ARONOW WS; GREENFIELD RS; ALIMADADIAN H et al.1977; AMER. J. CARDIOL.; U.S.A.; DA. 1977; VOL. 40; NO 5; PP. 789-793; BIBL. 23 REF.Article

EFFECTS AND MECHANISM OF ACTION OF TRIMAZOSIN ON CORONARY AND LEFT VENTRICULAR DYNAMICS IN CONSCIOUS DOGSMACHO P; VATNER SF.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 217; NO 2; PP. 333-339; BIBL. 16 REF.Article

Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metaboliteMEREDITH, P. A; KELMAN, A. W; ELLIOTT, H. L et al.Journal of pharmacokinetics and biopharmaceutics. 1983, Vol 11, Num 4, pp 323-335, issn 0090-466XArticle

Foetoplacental drug clearance in the rabbit: studies with trimazosin, acebutolol and tolmesoxidePRACH, A. T; RUBI, P. C.Xenobiotica (London. Print). 1988, Vol 18, Num 8, pp 967-972, issn 0049-8254Article

A double-blind comparison of trimazosin and metoprolol in patients with mild-to-moderate essential hypertensionSCARPAZZA, P; MEREGALLI, M; GUFFANTI, E. E et al.Current therapeutic research. 1987, Vol 42, Num 4, pp 620-626, issn 0011-393XArticle

Effect of a sustained-release formulation of trimazosin inmild to moderate hypertensionBYYNY, R. L; NIES, A. S; LO VERDE, M. E et al.Journal of clinical pharmacology. 1987, Vol 27, Num 2, pp 101-105, issn 0091-2700Article

Modelling the pharmacokinetics and pharmacodynamics of trimazosinKELMAN, A. W; MEREDITH, P. A; ELLIOTT, H. L et al.Biopharmaceutics & drug disposition. 1986, Vol 7, Num 4, pp 373-388, issn 0142-2782Article

Trimazosin in normotensive subjectsELLIOTT, H. L; VINCENT, J; HUGHES, D. M. A et al.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 2, pp 156-160, issn 0009-9236Article

Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertensionNELSON, G. I. C; SILKE, B; HUSSAIN, M et al.The American heart journal. 1984, Vol 108, Num 1, pp 124-131, issn 0002-8703Article

Long-term haemodynamic effects of sustained-release trimazosin at rest and during exercise in essential hypertensionOMVIK, P; LUND-JOHANSEN, P.European journal of clinical pharmacology. 1991, Vol 40, Num 2, pp 131-134, issn 0031-6970, 4 p.Article